Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Voyager Therapeut (VYGR)

Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 504,232
  • Shares Outstanding, K 54,394
  • Annual Sales, $ 250,010 K
  • Annual Income, $ 132,330 K
  • 60-Month Beta 0.96
  • Price/Sales 2.00
  • Price/Cash Flow 2.93
  • Price/Book 1.41
Trade VYGR with:

Options Overview Details

View History
  • Implied Volatility 81.58% ( -19.71%)
  • Historical Volatility 49.12%
  • IV Percentile 62%
  • IV Rank 37.84%
  • IV High 164.12% on 11/07/23
  • IV Low 31.35% on 11/09/23
  • Put/Call Vol Ratio 0.18
  • Today's Volume 40
  • Volume Avg (30-Day) 122
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 1,683
  • Open Int (30-Day) 2,689

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.38
  • Number of Estimates 5
  • High Estimate -0.22
  • Low Estimate -0.47
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +25.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.31 +26.81%
on 07/05/24
9.48 -2.22%
on 07/26/24
+1.47 (+18.85%)
since 06/26/24
3-Month
7.31 +26.81%
on 07/05/24
9.48 -2.22%
on 07/26/24
+1.65 (+21.65%)
since 04/26/24
52-Week
6.06 +52.97%
on 11/13/23
11.72 -20.90%
on 01/02/24
+0.48 (+5.46%)
since 07/26/23

Most Recent Stories

More News
Voyager Therapeutics: Q1 Earnings Snapshot

Voyager Therapeutics: Q1 Earnings Snapshot

VYGR : 9.27 (+0.87%)
Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics: Q4 Earnings Snapshot

VYGR : 9.27 (+0.87%)
S&P Futures Tick Lower as Key U.S. Jobs Report Looms

March S&P 500 E-Mini futures (ESH24) are trending down -0.23% this morning as investors looked ahead to the crucial monthly U.S. nonfarm payrolls report for further clues on the timing of possible interest-rate...

ESH24 : 5,101.67s (-1.01%)
WBA : 11.82 (+2.69%)
MBLY : 21.22 (+0.66%)
AAPL : 217.96 (+0.22%)
ALL : 169.17 (+2.28%)
EDV.LN : 1,708.844 (+1.72%)
LIGHT.NA : 22.420 (-7.20%)
PTON : 3.60 (+4.35%)
APLT : 5.22 (+0.38%)
IBM : 191.75 (-0.12%)
FUSN : 21.55 (+0.14%)
PLTR : 27.18 (+2.07%)
Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Therapeutics: Q3 Earnings Snapshot

VYGR : 9.27 (+0.87%)
Voyager Therapeutics: Q2 Earnings Snapshot

Voyager Therapeutics: Q2 Earnings Snapshot

VYGR : 9.27 (+0.87%)
2 Biotech Stocks That Could Make You Richer

These biotech companies are seeing a spike in revenue growth.

VYGR : 9.27 (+0.87%)
ZYME : 10.75 (+1.13%)
Voyager Therapeutics: Q1 Earnings Snapshot

Voyager Therapeutics: Q1 Earnings Snapshot

VYGR : 9.27 (+0.87%)
Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics: Q4 Earnings Snapshot

VYGR : 9.27 (+0.87%)
Why Voyager Therapeutics Stock Is Sinking This Week

Investors are taking profits on this red-hot stock this week.

VYGR : 9.27 (+0.87%)
NBIX : 146.80 (+0.48%)
Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Therapeutics: Q3 Earnings Snapshot

VYGR : 9.27 (+0.87%)

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

3rd Resistance Point 9.74
2nd Resistance Point 9.61
1st Resistance Point 9.44
Last Price 9.27
1st Support Level 9.14
2nd Support Level 9.01
3rd Support Level 8.84

See More

52-Week High 11.72
Fibonacci 61.8% 9.56
Last Price 9.27
Fibonacci 50% 8.89
Fibonacci 38.2% 8.22
52-Week Low 6.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar